Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
LOADING
|||
Switch Symbol:
Revenue Scaling
Trending higher, modest growth trend.
Left:
||||
Total revenue from sales of goods and services
Latest
$167.13M
Near historical average
Average (9y)
$159.35M
Historical baseline
Range
High:$251.45M
Low:$71.91M
CAGR
+9.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $167.13M | +27.3% |
| 2023 | $131.31M | -33.1% |
| 2022 | $196.25M | -18.8% |
| 2021 | $241.54M | +47.7% |
| 2020 | $163.56M | +36.0% |
| 2019 | $120.28M | -52.2% |
| 2018 | $251.45M | +78.2% |
| 2017 | $141.10M | +29.5% |
| 2016 | $108.97M | +51.5% |
| 2015 | $71.91M | - |